Introduction
============

Intensive fish farming favors the development of infectious diseases and consequently the use of antimicrobial agents for the treatment of bacterial infections has increased. One of the consequences of this practice is the selection of resistant bacteria carrying a wide variety of antimicrobial resistance encoding genes ([@B52]). Although Chile is the second largest salmon producer in the world, only a few studies concerning this problem have been developed, mostly studying the occurrence of genetic determinants encoding for resistance to oxytetracycline and florfenicol ([@B54]; [@B26]; [@B9]), the most used drugs in Chilean salmon farms, accounting for the 99.3% of the antimicrobials used in this industry during 2016 ([@B71]).

The salmon farming industry in Chile used a high amount of antibiotics, and among these, potentiated sulfonamides were included. Evidence exists that these antimicrobial agents are accumulated in the environments during treatments, leading to a change in the native bacterial composition. Thus, the selection of antibiotic resistant bacteria carrying different resistance genes is expected. In the case of those inserted in plasmids and/or integrons, they can be disseminated to susceptible bacteria in different environments ([@B10]; [@B83]).

Despite the fact that sulfonamides are not longer authorized for used in Chilean salmon farms they were extensively used prior to introduction of drug use regulations. According to the SERNAPESCA reports ([@B70]), 2009 was the last year when potentiated sulfonamides were used in the Chilean salmon industry, mainly to treat the pathogens *Flavobacterium psychrophilum* and *Streptococcus phocae*, but using only very low quantities, corresponding to the 0.01% (2008 and 2009) and 0.02% (2007) of the total amount of drug used ([@B70]; [@B53]). Furthermore, despite sulfonamides were banned for their use in Chilean salmon industry many years ago, the presence of bacteria carrying genes encoding for their resistance could be still prevalent in Chilean salmon farm environments considering the feasibility of their co-selection when other antibacterial agents such as where florfenicol or oxytetracycline are administered in fish farms.

The most frequent mechanism of bacterial resistance to sulfonamides is the acquisition of the dihydropteroate synthase enzyme encoded by the genes *sul1, sul2* and *sul3* ([@B32]; [@B63]; [@B7]; [@B82]). While the *sul1* gene is mainly associated with class 1 integrons, the *sul2* gene has been detected on various plasmids but not associated with integrons ([@B7]; [@B82]), whereas the *sul3* gene has been linked to class 1 integrons lacking their 3′ CS region ([@B7]). Integrons are composed of two very conserved DNA regions, located at their ends, which are known as 5′ CS and 3′ CS (5′ and 3′ conserved segments), and between both zones one or more antibiotic resistance genes could be inserted ([@B64]; [@B11]; [@B21]). Acquisition and dissemination of these genes located within the integron structure results in an increase in antimicrobial resistance. Three classes of integron structure have been described ([@B11]; [@B21]). Class 1 integrons are of principal importance in clinical isolates. The 5′-CS of class 1 integrons includes an *intI1* gene, which encodes for a specific recombinase. This gene contains the *att1* recombination site, required for specifically integrating gene cassettes. The 3′-CS region contains several open reading frames (ORFs). These include *qacEΔ1*, which confers resistance to quaternary ammonium compounds, often associated with antiseptics, along with a *sul1* gene expressing resistance to sulfonamides ([@B62]; [@B61]). Resistance to trimethoprim is mainly mediated by a dihydrofolate reductase enzyme encoded by the *dfr* genes, which are usually associated with class 1 and class 2 integrons or plasmids ([@B86]; [@B34]).

This association of *sul* and *dfr* genes with mobile genetic elements such as plasmids and integrons, is highly relevant for the increase in the emergence, evolution, and dissemination of sulfonamide resistance in aquatic environments. It has been extensively reported that a high number of strains resistant to florfenicol and oxytetracycline usually exhibit simultaneous resistance to sulfonamides ([@B56]; [@B55]; [@B26]), currently the most used drugs in the Chilean salmonid industry ([@B71]).

In a recent study some sulfonamide-resistance genes were studied among several isolates recovered close to a Chilean salmon farm. A low number of isolates carrying a *sul1* gene and positive for the *intI1* integrase gene were detected, but their ability to be transferred was not detected ([@B72]). Considering the role of environmental bacteria as reservoirs of antimicrobial resistance genes and the importance of salmon farming in Chile, in this study, we aimed to investigate the occurrence of *sul* and *dfr* genes, their relationship with integrons, as well as assess their capacity to be transferred by conjugation among sulfonamide- and/or trimethoprim-resistant strains recovered from various sources of Chilean salmon farms.

Materials and Methods {#s1}
=====================

Bacterials Strains
------------------

The study included 91 Gram-negative bacilli strains resistant to sulfisoxazole and/or trimethoprim recovered from a collection of bacteria obtained from seven salmon farms located in the South of Chile where the Chilean salmonid industry is concentrated ([Figure 1](#F1){ref-type="fig"}). Fourteen strains were recovered from the land-based farms (facilities for salmonid growth until smoltification carried out in tanks located in land-based hatcheries), F1 and F2 (7 strains from each farm), and 77 strains were recovered from the lake-based farms (salmonids raised in fish cages located in freshwater lakes), C1 (6 strains), C2 (7 strains), C3 (32 strains), C4 (14 strains), and C5 (18 strains). Land-based salmonid farms F1 and F2 were located near Lake Llanquihue and Quellón Bay, respectively, whereas lake-based farms were located in the Lake Puyehue (C1), Lake Rupanco (C2 and C3) and Lake Llanquihue (C4 and C5) ([Figure 1](#F1){ref-type="fig"}).

![Geographic location of Chilean salmon farms, where sulfonamide- and/or trimethoprim-resistant strains were recovered, including land-based farms (F1--F2) and lake-based farms (C1--C5).](fmicb-10-00748-g001){#F1}

Strains from land-based culture centers were isolated from various sources, including un-medicated fish food pellet, salmonid fingerling and water samples from fish farm effluent and fish rearing tanks. Strains recovered from lake-based salmonid cultures were isolated from samples of mucus and intestinal content of reared fish, surface water samples from salmon cages and un-impacted control sites, as well as samples of sediments beneath salmonid cages and control sites. Samples were collected and processed as previously described ([@B56]; [@B55]). Purified strains were stored at −85°C in CryoBank (Mast Diagnostic) vials until use.

Bacterial Identification
------------------------

Phenotypical characteristics, Gram stain, oxidase production and oxidative/fermentative utilization of glucose were determined for the 91 studied strains. The Gram reaction of strains was determined using the Gram stain ([@B6]), oxidase production was determined by the method described by [@B6], and the oxidative/fermentative (O/F) test was carried out according to [@B36]. Strains were further characterized by using the GN Microplate system (Biolog, Inc., Hayward, CA, United States) according to [@B55] and a number of strains (20%) were reexamined to check reproducibility of the assay. Bacterial identification was performed by using the Microlog System 4.2 identification software (Biolog, Inc.).

The identity of thirty sulfisoxazole- and/or trimethoprim-resistant strains positive for any of the studied genes was confirmed by bacterial 16S rRNA gene sequence analysis. For DNA extraction, the bacterial strains were cultured in Tryptic Soy Agar (TSA, Difco labs) for 2 days, and total genomic DNA was extracted from each strain using the PureLink genomic DNA kit (Invitrogen). The extracted DNA was amplified by polymerase chain reaction (PCR) using the eubacterial 16S rDNA primers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R (5′-GGTTACCTTGTTACGACTT-3′) described by [@B44] and PCR products were purified using the Wizard SV Gel kit and PCR Clean-up System (Promega). Sequencing of amplicons was performed by Macrogen using the ABI PRISM 373 DNA Sequencer (Applied Biosystems) with ABI PRISM cycle sequencing kit (Macrogen, South Korea). Primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′), 907R (5′-CCGTCAATTCCTTTRAGTTT-3′) and 1492R (5′-TACGGYTACCTTGTTACGACTT-3′) were used for sequencing. Sequence data was aligned and compared with available standard sequences of bacterial lineage in the GenBank database (NCBI) using Basic Local Alignment Search Tool. The partial sequences of the 16S rDNA gene belonging to each strain were deposited in the GenBank database under accession numbers [KX279647](KX279647) to [KX279675](KX279675), and [MH424518](MH424518).

Minimum Inhibitory Concentrations (MICs)
----------------------------------------

Minimum inhibitory concentrations (MICs) of sulfisoxazole and trimethoprim against all strains were determined by an agar dilution method, as recommended by the Clinical and Laboratory Standards Institute (CLSI) guideline M07-A9 ([@B16]). A serial twofold dilution pattern of the antibiotic was added into Mueller--Hinton agar (Difco) so as to obtain final concentrations ranging from 0.5 to 2,048 μg mL^−1^. Bacterial suspensions were prepared in sterile 0.85% saline and triplicate plates were inoculated using a Steers replicator apparatus ([@B76]), delivering approximately 10^4^ colony-forming units per spot, and incubated for 48 h at 22°C. The first and last agar plates did not contain any antibiotic in order to detect possible contamination of the strains or antibiotic carryover. MIC was defined as the lowest concentration of the antibacterial agent producing absence of growth at least in two of the three plates after 48 h. Reference strain *Escherichia coli* ATCC 25922, recommended by CLSI ([@B16]), was used as quality control organism for verification of MIC ranges on Mueller--Hinton agar plates.

Antimicrobial Resistance Patterns
---------------------------------

Sulfisoxazole- and/or trimethoprim-resistant strains were tested for their susceptibility to 15 antimicrobials by an agar disk diffusion method as described in the CLSI guideline VET03-A ([@B14]), using Müeller--Hinton agar (Difco). The antibacterial susceptibility patterns of resistant strains were performed using disks containing the antibacterial agents: amoxicillin (AML, 25 μg), cefotaxime (CTX, 30 μg), streptomycin (S, 10 μg), kanamycin (K, 30 μg), gentamicin (CN, 10 μg), erythromycin (E, 15 μg), chloramphenicol (CM, 30 μg), florfenicol (FFC, 30 μg), oxytetracycline (OT, 30 μg), oxolinic acid (OA, 2 μg), flumequine (UB, 30 μg), enrofloxacin (ENR, 5 μg), furazolidone (FR, 100 μg), sulfisoxazole (SFX, 300 μg), and trimethoprim (TMP, 5 μg). All disks were obtained from Oxoid, Ltd. (Basingstoke, Hampshire, England). Bacterial strains were suspended in sterile 0.85% saline to a turbidity to match a McFarland No. 2 standard (bioMerieux S.A.), diluted 1:20, and streaked on the used media. Plates were incubated for 24--48 h at 22°C and *E. coli* ATCC 25922 was used as the control strain, as recommended by the CLSI ([@B17]). Characterization of strains as resistant was stated according to standards suggested by CLSI ([@B15]) or by [@B55]. A number of strains (20%) were re-examined to check reproducibility of the assay.

Detection of *sul* and *dfr* Genes
----------------------------------

The detection of genes encoding for resistance to sulfonamide (*sul1, sul2*, and *sul3*) and trimethoprim (*dfrA1, dfrA5, dfrA6, dfrA7, dfrA8, dfrA9, dfrA10, dfrA12, dfrA13, dfrA14, dfrA17, dfrA20, dfrB1, dfrB2, dfrB3*) was made using PCR using specific primers previously described ([@B32]; [@B63]) or designed in this study ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). Colonies from an overnight culture on Mueller Hinton agar at 22°C were resuspended in 200 μL of 5% Chelex (BioRad) and 25 μL of 20 mg mL^−1^ proteinase K (Invitrogen) were added. The suspension was incubated for 45 min at 56°C followed by 8 min at 100°C, then centrifuged at 14,000 rpm and the supernatant was used as template. The PCR mixtures (25 μL of total volume) consisted of 2.5 μL of Taq reaction buffer 10× (Invitrogen), 0.75 μL of MgCl~2~ (50 mM, Invitrogen), 0.25 μL dNTPs (25 mM each, Invitrogen), 0.125 μL of each primer (25 pmoL μL^−1^, Invitrogen), 0.2 μL Taq polymerase (5 U μL^−1^, Invitrogen), and 2 μL of template DNA.

###### 

Primers used to detect *sul* genes.

  Gene     Primer        Sequence (5′--3′)                                   Amplicon size (bp)   References
  -------- ------------- --------------------------------------------------- -------------------- ------------
  *sul1*   Sul1F Sul1R   GTATTGCGCCGCTCTTAGAC CCGACTTCAGCTTTTGAAGG           408                  [@B67]
  *sul2*   Sul2F Sul2R   GAATAAATCGETCATCATTTTCGC CGAATTCTTGCGGTTTCTTTCAGC   810                  [@B32]
  *sul3*   Sul3F Sul3R   GAGCAAGATTTTTGGAATCG CATCTGCAGCTAACCTAGGGCTTTGG     790                  [@B63]

###### 

Primers used to detect *dfr* genes.

                   Primer     Sequence (5′--3′)           Amplicon size (bp)   References
  ---------------- ---------- --------------------------- -------------------- ------------
  *dfrA1*          D1         ACGGATCCTGGCTGTTGGTTGGAC    257                  [@B46]
                   D2         GCAATTCACCTTCCGGCTCGATGTC                        
  *dfrA5^∗^*       D3         GTTGCGGTCCAGACATAC          253                  [@B46]
  *dfrA14^∗^*      D4         CCGCCACCAGACACTA                                 
  *dfrA6*          DfrA6-F    ATATCTCTTATGGCAGCTGTTTCC    420                  This study
                   DfrA6-R    ACTTTGCTCAAATGTTTTGCTTG                          
  *dfrA7*          DfrA7-F    TCTGCAACGTCAGAAAATGG        404                  This study
                   DfrA7-R    TGCTCAAAAACCAAATTGAAA                            
  *dfrA8*          D5         TCGAGCTTCATGCCATTT          454                  [@B46]
                   D6         TCTTCCATGCCATTCTGC                               
  *dfrA9*          D11        CAGATTCCGTGGCATGAACC        390                  [@B78]
                   D12        GACCTCAGATACGAGTTTCC                             
  *dfrA10*         DfrA10-F   TATCACTTATCTTTGCGA          537                  [@B31]
                   DfrA10-R   GGCACCCCAACCAGCGAA                               
  *dfrA12*         DfrA12-F   TTTATCTCGTTGCTGCGATG        457                  This study
                   DfrA12-R   TAAACGGAGTGGGTGTACGG                             
  *dfrA13*         DfrA13-F   TCGGAAAAGAGGGAAAGATG        401                  This study
                   DfrA13-R   GGAGGTCTCCCCTCCTACCT                             
  *dfrA17*         DfrA17-F   CCGCTTAATCGGTAGTGGTC        432                  This study
                   DfrA17-R   TTTTTCCAAATCCGGAATGTAT                           
  *dfrA20*         D15        GGGAAACACCGAGAAATGGG        407                  [@B78]
                   D16        TTCTTCTTCCCATTCTCCCC                             
  *dfrBl, dfrB2*   Dfr11-F    GATCACGTGCGCAAGAAATC        141                  [@B59]
  *dfrB3^∗∗^*      Dfr11-R    AAGCGCAGCCACAGGATAAAT                            

∗

Primers used to amplify dfrA5 gene also amplify the dfrA14 gene.

∗∗

Primers used to amplify dfrB1 gene also amplify the dfrB2 and dfrB3 genes.

Polymerase chain reaction products were detected by electrophoresis in 1.5% agarose gels and visualized by ultraviolet illumination after staining with ethidium bromide (0.5 mg L^−1^).

Detection and Characterization of Class 1 and Class 2 Integrons
---------------------------------------------------------------

The occurrence of class 1 and class 2 integrons was detected using PCR, amplifying intragenic fragments using specific primers for each gene ([Table 3](#T3){ref-type="table"}), according to previously described methodologies ([@B67]; [@B51]). PCR products for *intI1* (class 1 integron) gene were confirmed using restriction enzymes, considering that SphI enzyme produces two fragments (393 and 499 bp), whereas no strains positive for *intI2* were found. Additionally, in strains carrying class 1 integrons their whole integron gene cassettes were amplified using a combination of pair of primers which align in the zone of the integrase gene and the possible gene inserted as cassette in reverse. Similarly, combinations of primers which amplify the possible gene inserted as cassette and primers which align in the 3′ CS end of the integron were used. The obtained amplification products were purified by using Wizard PCR Preps (Promega) and sequenced using the Macrogen, United States sequencing service.

###### 

Primers used for PCR detection of integrons and associated gene cassette regions.

  Integron   Primer   Sequence (5′--3′)            References
  ---------- -------- ---------------------------- ------------
  Class 1    IntA     GTCAAGGTTCTGGACCAGTTGC       [@B67]
             IntB     ATCATCGTCGTAGAGACGTCGG       
             CASS1    TGATCCGCATGCCCGTTCCATACAG    [@B67]
             CASS2    GGCAAGCTTAGTAAAGCCCTCGCTAG   
             5′ CS    GGCATCCAAGCAGCAAG            [@B47]
             3′ CS    AAGCAGACTTGACCTGA            
             qacF     GGCTGGCTTTTTCTTGTTATC        [@B51]
             qacR     TGAGCCCCATACCTACAAAGC        
             Orf4     CTAGCGAGGGCTTTACTAAGCTTGCC   [@B67]
  Class 2    Intl2F   GCAAATGAAGTGCAACGC           [@B51]
             Intl2R   ACACGCTTGCTAACGATG           

Isolation of Plasmid DNA
------------------------

Bacterial strains (30 strains) harboring a studied gene (*sul1*, *sul2*, *dfrA1*, *dfrA12*, *dfrA14*, and *intI1*) were screened for their plasmid content. The plasmid isolation was made using a geneJET Plasmid miniprep kit (Thermo Scientific) according to the manufacturer's instructions. The plasmid DNA obtained was run on 1.5% agarose gel electrophoresis for plasmids less than 20 kb and 0.8% agarose gel for plasmid greater than 20 kb. Gels were stained with GelRed^TM^ (Biotium) and viewed by UV transillumination. The size was estimated by comparing with known plasmid weight standards and standard molecular weight markers.

Mating Experiments
------------------

Twenty-two strains were selected according their resistance pattern, MIC levels and carriage of *sul* and/or *dfr* genes and integrons, to evaluate their ability to transfer these determinants by conjugation in liquid medium according to the methodology described by [@B1]. A mutant of *E. coli* K-12 resistant to nalidixic acid, rifampicin and sodium azide was used as the recipient. Transconjugants were selected on MacConkey agar plates containing sodium azide (300 μg mL^−1^) and sulfisoxazole (512 μg mL^−1^) and tested for the presence of the antimicrobial resistance genes by PCR as previously described.

Results
=======

Bacterial Identification
------------------------

Out of the 91 Gram-negative bacilli strains studied, 85 (93.4%) were glucose non-fermenting bacteria, and only 6 (18.6%) were glucose fermenters. Most of the strains belonged to the *Pseudomonas* genus (81 strains), with a high frequency of *P. fluorescens* and *P. putida* (21 and 18 strains, respectively), whereas strains belonging to other non-fermenting genre included *Acinetobacter johnsonii*, *Brevundimonas vesicularis* and *Sphingobacterium multivorum* and were isolated at low frequency ([Table 4](#T4){ref-type="table"}). The glucose-fermenting strains were all recovered from lake-based farms and were identified as *Citrobacter gillenii*, *C. freundii*, *Kluyvera intermedia*, *Comamonas* sp., *Hafnia* sp., and *Raoultella terrigena* ([Table 4](#T4){ref-type="table"}). When the 30 sulfonamide- and/or trimethoprim-resistant strains positive for any of the assayed genes were identified by amplifying their 16S rRNA genes, a high predominance of representatives of the *Pseudomonas* genus (22 strains), mainly belonging to the *P. fluorescens* (6), *P. putida* (6), and *P. baetica* (3) species was observed, whereas most of the enteric strains included in the study, identified as *C. gillenii*, *C. freundii*, *Hafnia* sp., *Comamonas* sp. and *K. intermedia*, harbored at least one of the detected genes ([Table 4](#T4){ref-type="table"}).

###### 

Identification of resistant strains recovered from Chilean salmonid farms.

  Species                         Number of strains   Total                                              
  ------------------------------- ------------------- ------- ------- ------- -------- -------- -------- --------
  *Acinetobacter johnsonii*                           2                                                  2
  *Brevundimonas vesicularis*                                 1                                          1
  *Citrobacter freundii*                                                               1                 1
  *Citrobacter gillenii*                                      1                                 1        1
  *Comamonas* sp.                                                                               1        1
  *Hafnia* sp.                                                                                  1        1
  *Kluyvera intermedia*                                       1                                          1
  *Pseudomonas aeruginosa*                            1                                                  1
  *Pseudomonas arsenicoxydans*                                                                           1
  *Pseudomonas baetica*                                               1       1        1                 3
  *Pseudomonas fluorescens*       4                   2       3       2       2        4        4        21
  *Pseudomonas jessenii*                                                      1        1                 2
  *Pseudomonas gessardii*         1                                                                      1
  *Pseudomonas lini*                                                                   1                 1
  *Pseudomonas ludensis*                                                      3                          3
  *Pseudomonas lurida*                                                        1                          1
  *Pseudomonas maculicola*                                                    4                          4
  *Pseudomonas migulae*                               1                                                  1
  *Pseudomonas nitroreducens*                                                 1                 1        2
  *Pseudomonas oryzihabitans*                                                          1                 1
  *Pseudomonas putida*            1                                           8        2        7        18
  *Pseudomonas* sp.               1                                   2       5                          8
  *Pseudomonas synxantha*                                                     2        1                 3
  *Pseudomonas syringae*                              1                                         1        2
  *Pseudomonas veronii*                                               1                                  1
  *Pseudomonas viridilivida*                                                  4                 2        6
  *Pseudomonas vranovensis*                                                            1                 1
  *Raoultella terrígena*                                              1                                  1
  *Sphingobacterium multivorum*                                                                 1        1
  **Total**                       **7**               **7**   **6**   **7**   **32**   **14**   **18**   **91**

Minimum Inhibitory Concentrations (MICs)
----------------------------------------

Resistant strains exhibited high MIC values of sulfisoxazole and trimethoprim, not observing remarkable differences among strains from different farms and sources ([Table 5](#T5){ref-type="table"}). Sulfisoxazole MIC values of strains varied between 64 and ≥4,016 μg mL^−1^, with MIC~50~ and MIC~90~ values of 2,046 and ≥ 4,096 μg mL^−1^, respectively, whereas trimethoprim MIC values ranged from 4 to ≥2,048 μg mL^−1^, with MIC~50~ and MIC~90~ values of 2,046 and ≥2,046 μg mL^−1^, respectively ([Table 5](#T5){ref-type="table"}). Thus, strains showed high levels of resistance, considering that breakpoint values for categorizing resistance for these antibacterials are 16 μg mL^−1^ for trimethoprim and 512 μg mL^−1^ for sulfisoxazole ([@B18]). Reference strain *E. coli* ATCC 25922, used for quality control exhibited MIC values of sulfisoxazole and trimethoprim of 8 and 0.5 μg mL^−1^, respectively, which agrees with the values recommended by [@B18].

###### 

Sulfixosazole (SFX) and trimethoprim (TMP) minimum inhibitory concentrations (MIC, in μg mL^−1^) of resistant strains recovered from Chilean salmonid farms.

  Farm         Number of Strains   SFX         TMP                                                        
  ------------ ------------------- ----------- ------------- ------------------ ----------- ------------- -----------------
  Land-based                                                                                              
  F1           7                   512         \>4,096       64 −\> 4,096       \>2,048     \>2,048       256 −\> 2,048
  F2           7                   \>4,096     \>4,096       4,096 −\> 4,096    \>2,048     \>2,048       2,048 −\> 2,048
  Lake-based                                                                                              
  C1           6                   \>4,096     \>4,096       \>4,096            2,048       \>2,048       2,048 −\> 2,048
  C2           7                   4,096       \>4,096       512 −\> 4,096      2,048       \> 2,048      64 −\> 2,048
  C3           32                  512         2,048         64 −\> 4,096       2,048       \>2,048       256 −\> 2,048
  C4           14                  \>4,096     \>4,096       512 −\> 4,096      2,048       \>2,048       512 −\> 2,048
  C5           18                  4,096       \>4,096       128 −\> 4,096      2,048       \>2,048       4 −\> 2,048
  **Total**    **91**              **2,048**   \>**4,096**   **64 −\> 4,096**   **2,048**   \>**2,048**   **4 −\> 2,048**

Antimicrobial Resistance Patterns
---------------------------------

Strains used in the study were resistant to sulfisoxazole (85.7%) and/or trimethoprim (98.9%). A high percentage of strains exhibited resistance to chloramphenicol and florfenicol (98.9%), erythromycin (95.6%) and furazolidone (90.1%). In addition, a high incidence of resistance to amoxicillin (78.0%), as well as an intermediate resistance to oxolinic acid (45.1%), oxytetracycline (34.1%), gentamicin (34.1%), and cefotaxime (26.4%) was observed in the strains ([Figure 2](#F2){ref-type="fig"}). Otherwise, a low incidence of resistance to enrofloxacin (3.3%), kanamycin (12.1%), and flumequine (19.8%), was detected among the studied strains ([Figure 2](#F2){ref-type="fig"}). None of the strains was susceptible to less than four antimicrobial agents. Moreover, 51.9% and 26.7% of the strains showed simultaneous resistance to 7 and 8 antibacterial agents, respectively. Among the 13 strains exhibiting susceptibility to sulfisoxazole, were those recovered from farms F1 (2), C3 (9), and C5 (2), whereas the strain susceptible to trimethoprim was recovered from farm C5.

![Frequency of resistance to antibacterials of 91 sulfonamide- and/or trimethoprim-resistant strains isolated from Chilean salmon farms. AML, amoxicillin; CTX, cefotaxime; S, streptomycin; CN, gentamicin; K, kanamycin; E, erythromycin; CM, chloramphenicol; FFC, florfenicol; OT, oxytetracycline; OA, oxolinic acid; UB, flumequine; ENR, enrofloxacin; FR, furazolidone; SFX, sulfisoxazole; TMP, trimethoprim.](fmicb-10-00748-g002){#F2}

Detection of *sul* and *dfr* Genes
----------------------------------

An important number of the sulfonamide-resistant strains (28 out of 78 strains; 35.9%) carried a *sul* gene, and among them 18 strains carried a class 1 integron ([Figure 3](#F3){ref-type="fig"}). Among these, 22 harbored the *sul1* gene, 3 carried the *sul2* gene and 3 strains carried both genes ([Figure 3](#F3){ref-type="fig"}). The *sul1* gene was detected in strains recovered from all 7 salmon farms, distributed in 8 out of 12 (66.7%) and 17 out of 66 (25.8%) from land-based and lake-based farms, respectively, whereas *sul2* was found only in strains from four farms ([Figure 3](#F3){ref-type="fig"}). On the other hand, none of the studied strains carried the *sul3* gene. The majority of *sul*-positive strains were found among the strains exhibiting the highest MICs of sulfisoxazole; considering that 20/22 strains carrying *sul1* as well as 4 strains harboring *sul2* had MIC values of ≥4,098 μg mL^−1^ ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}). It must be noted that 18 strains recovered from surface water (3 strains) and sediments (15 strains) from non-aquaculture unpolluted sites but exhibiting resistance to sulfisoxazole and/or trimethoprim were included in the study, but none of them were positive for any of the assayed genes.

![Frequency of *sul* and *dfr* genes among 91 sulfonamide- and/or trimethoprim-resistant strains isolated from Chilean salmon farms.](fmicb-10-00748-g003){#F3}

When the presence of *dfrA* and *dfrB* genes was investigated, only the *dfrA1*, *dfrA12*, and *dfrA14* genes were detected, distributed in 12 of the 90 trimethoprim-resistant strains, with a predominance of *dfrA12* gene (8/12 strains). The distribution of *dfr* genes was similar in strains isolated from land-based (13.6%) and lake-based (11.7%) farms. In addition, it must be noted that two strains belonging to the *Citrobacter* genus, simultaneously carried two different genes encoding for resistance to trimethoprim (*C. gillenii* FP75 carried *dfrA1* and *dfrA12* genes and strain *C. freundii* FB98 carried *dfrA12* and *dfrA14* genes) ([Figure 3](#F3){ref-type="fig"}).

Detection and Characterization of Integrons
-------------------------------------------

In this study, 21 out of 91 strains (23.1%) harbored a class 1 integron, whereas *intl2* integrase was not detected among the studied strains. This genetic structure was present in bacterial strains from land-based (6/14; 42.9%) and from lake-based (19/77; 24.7%) farms. Among strains carrying a class 1 integron, 17 strains showed a 3′ CS end with the *qacEΔ1* gene adjacent to the *sul1* gene, but 4 of them had a modified gene *qacEΔ1*, whereas in another four strains positive for the integrase *intI1* it was not possible to amplify the 3′ CS end of their integrons. As observed with strains carrying the *sul* and *dfr* genes, the integrons were concentrated in strains with high levels of resistance to trimethoprim and/or sulfisoxazole ([Table 6](#T6){ref-type="table"}). An important number of strains (17 strains) carried a *sul* gene inserted in integrons ([Table 6](#T6){ref-type="table"}).

###### 

Identification, integron structure, location of *sul* and *dfr* genes and plasmid content among sulfonamide- and/or trimethoprim-resistant strains.

  Strain                              Farm   Source               Class of integron integrase   3′-CS   Gene cassettes inside the Variable Zone (From 5′ to 3′)   *sul* and *dfr* genes outside the integron   Plasmid content   
  ----------------------------------- ------ -------------------- ----------------------------- ------- --------------------------------------------------------- -------------------------------------------- ----------------- ---------
  *Pseudomonas jessenii* OT42         F1     Mucus                --                            −       --                                                        *sul1*                                       1                 10
  *Pseudomonas putida* 0233           F1     Tank water           *intI1*                       \+      *aadA1*                                                   --                                           1                 33
  *Pseudomonas migulae* Q11           F2     Tank water           *intI1*                       \+      *aadA1*                                                   --                                           0                 
  *Pseudomonas fluorescens* Q20       F2     Fingerling           *intI1*                       \+      --                                                        --                                           1                 25
  *Pseudomonas fluorescens* Q23       F2     Fingerling           *intI1*                       \+      *aadA1*                                                   --                                           0                 
  *Pseudomonas syringae* Q64          F2     Effluent             *intI1*                       \+      --                                                        --                                           1                 10
  *Acinetobacer johnsonii* Q67        F2     Pellet               *intI1*                       \+      *aadA1*                                                   *dfrA1, sul2*                                1                 10
  *Acinetobacer johnsonii* Q75        F2     Pellet               *intI1*                       \+      *aadA1*                                                   --                                           1                 30
  *Pseudomonas fluorescens* FP37      C1     Mucus                *intI1*                       \+      *aadA2, cmlA*                                             *dfrA12*                                     1                 10
  *Pseudomonas fluorescens* FP45      C1     Mucus                *intI1*                       \+      *aadA2, cmlA*                                             *dfrA12*                                     1                 10
  *Pseudomonas fluorescens* FP47      C1     Mucus                *intI1*                       \+      *aadA2, cmlA*                                             *dfrA12*                                     1                 30
  *Citrobacter gillenii FP75*         C1     Mucus                *intI1*                       \+      *dfrA12, orfF, aadA2a*                                    *dfrAl, sul2*                                1                 10
  *Kluyvera intermedia* OP29          C1     Cage sediment        *intI1*                       \+      *dfrA12, orfF, aadA2*                                     *sul2*                                       1                 10
  *Pseudomonas baetica* FE3           C2     Cage water           --                            −       --                                                        *sul1*                                       2                 0.25/25
  *Pseudomonas veronii* FE4           C2     Cage water           --                            −       --                                                        *sul1*                                       0                 
  *Pseudomonas putida* FF32           C3     Cage water           *intI1*                       −       --                                                        --                                           1                 10
  *Pseudomonas baetica* SX52          C3     Mucus                *intI1*                       \+      *aadA9*                                                   *dfrA12*                                     1                 30
  *Pseudomonas putida* FB13           C4     Mucus                --                            −       --                                                        *sul1*                                       1                 30
  *Pseudomonas putida* FB 15          C4     Mucus                *intI1*                       −       --                                                        *dfrA14, sul1*                               1                 10
  *Citrobacter freundii* FB98         C4     Mucus                *intI1*                       \+      *dfrA12, orfF, aadA2*                                     *dfrA14*                                     1                 3
  *Pseudomonas fluorescens* FR27      C4     Mucus                *intI1*                       \+      *aadA2, cmlA*                                             *dfrA12*                                     2                 10/40
  *Pseudomonas baetica* FR34          C4     Mucus                --                            −       --                                                        *sul2*                                       2                 0.6/25
  *Pseudomonas jessenii* FR51         C4     Mucus                --                            −       --                                                        *sul1*                                       0                 
  *Pseudomonas arsenicoxydans* SR72   C4     Intestinal content   --                            −       --                                                        *sul1*                                       1                 25
  *Sphingobacterium multivorum* FM2   C5     Cage water           --                            −       --                                                        *sul2*                                       1                 40
  *Comamonas* sp. FM3                 C5     Cage water           *intI1*                       \+      *aadA2*                                                   --                                           2                 1/10
  *Pseudomonas syringae* FM4          C5     Cage water           *intI1*                       \+      --                                                        --                                           2                 10/37
  *Hafina sp*. FM7                    C5     Cage water           *intI1*                       −       --                                                        --                                           2                 2.5/10
  *Pseudomonas putida* FM15           C5     Mucus                *intI1*                       −       --                                                        *sul2*                                       1                 30
  *Pseudomonas putida* FM22           C5     Mucus                --                            −       --                                                        *sul1, dfrA14*                               1                 10

3′ CS, 3′ conserved segment of class-1 integrons harboring the gene array qacEΔ1 + sul1.

Fourteen variable zones were found among the detected class 1 integrons, carrying 1 to 3 gene cassettes. Five genes encoding for resistance to trimethoprim (*dfrA12*), aminoglycosides (*aadA1*, *aadA2*, and *aadA9*), and chloramphenicol (*cmlA*) were identified as part of the integron structures, being found either alone or in combination with other gene cassettes ([Table 6](#T6){ref-type="table"}). The variable regions with one cassette harbored the genes *aadA1* (five strains), *aadA2* (one isolate) and *aadA9* (one isolate). The strains with two cassettes inserted in its variable region carried *aadA2*-*cmlA* (four strains). Finally, three strains were found to carry three gene cassettes in their variable zones containing the genes *dfrA12-orf-aadA2* (two strains) and *dfrA12-orf-aadA2a* (one strain). Otherwise, in three strains the variable zone of their integrons could not be determined, despite using various primer combinations ([Table 6](#T6){ref-type="table"}).

###### 

Transfer of *sul* and *dfr* genes and integrons from resistant strains to *Escherichia coli* K-12.

  Donor   Transconjugant   Frequency of transfer^∗^                                                    
  ------- ---------------- -------------------------- ---------------- ------------------------------- --------------
  FB98    1                *dfrA12, orfF, aadA2*      --               S-CM-FFC-OT-NA-SFX-TMP-NaN~3~   7.4 × 10^−3^
  FM4     1                --                         --               S-CM-FFC-OT-NA-SFX-NaN~3~       1.4 × 10^−3^
  FM7     1                --                         --               NA-TMP-NaN~3~                   5.4 × 10^−3^
  FM22    --               --                         *sul1, dfrA14*   S-CM-FFC-OT-NA-SFX-TMP-NaN~3~   2.6 × 10^−5^
  FP45    1                *aadA2, cmlA*              --               S-CM-NA-TMP-NaN~3~              4.1 × 10^−3^
  FP75    1                *dfrA12, orfF, aadA2*      *sul2*           S-CM-FFC-OT-NA-SFX-TMP-NaN~3~   9.8 × 10^−4^
  OP29    1                *dfrA12, orfF, aadA2*      *sul2*           S-CM-FFC-OT-NA-SFX-TMP-NaN~3~   8.4 × 10^−3^
  SX52    1                *aadA9*                    *dfrA12*         S-NA-TMP-NaN~3~                 5.0 × 10^−4^
  OT42    --               --                         *sul1*           S-NA-TMP-NaN3                   1.7 × 10^−3^
  FR27    1                *aadA2, cmlA*              *dfrA12*         S-CM-FFC-NA-TMP-NaN~3~          3.1 × 10^−5^
  FE3     NT                                                                                           
  FM2     NT                                                                                           
  FM3     NT                                                                                           
  Q20     NT                                                                                           
  Q64     NT                                                                                           
  Q67     NT                                                                                           
  Q75     NT                                                                                           
  0233    NT                                                                                           
  FB13    NT                                                                                           
  FB15    NT                                                                                           
  FR34    NT                                                                                           
  SR72    NT                                                                                           

VZ, variable zone;

∗

transconjugant per recipient cell; S, streptomycin; CM, chloramphenicol; FFC, florfenicol, OT, oxytetracycline; NA, nalidixic acid; SFX, sulfisoxazole; TMP, trimethoprim; NaN

3

, sodium azide; NT, not transfer detected.

It must be noted that various strains harboring a class 1 integron carried genes encoding for resistance to sulfonamides and trimethoprim not inserted in the integron structure. For the *dfr* genes two situations were seen, the presence of *dfr* genes in strains with integrons, but not associated with these structures, and the presence of more than one *dfr* gene per strain (associated and not associated with integron). In the case of *sul* genes, these were found mainly associated with class 1 integrons, with *sul1* as part of the integron, whereas *sul2* was not present as a gene cassette, but rather associated with other structures ([Table 6](#T6){ref-type="table"}).

The *dfrA12* gene encoding for the enzyme dehidrofolate reductase XII, carried by the FP75, FB98 and OP29 strains, was analyzed using the 5′ CS/dfrA12 R, dfrA12 F/3′ CS and dfrA12F/sul1R primers, and the cassette was found to be located adjacent to the integrase gene. In addition, when amplicons were sequenced, two cassettes were detected, corresponding to the *orf* and *aadA2a* genes (FP75 strain), and *orf* and *aadA2* genes (FB98 and OP29 strains). These genes were adjacent to the *qacEΔ1* gene in the 3′ CS end, presenting a 100% similarity to the *dfrA12*, *orfF*, and *aadA2a* genes included in the GenBank database under the Accession No. DQ322593.

Plasmid Content
---------------

Plasmid DNA was detected in 25 out of 30 resistant strains examined, and from these, six strains contained two plasmid bands. The number and size of plasmid bands found are shown in [Table 6](#T6){ref-type="table"}. The most commonly found plasmid band had a molecular weight of 10 kb (13 strains) followed by plasmids with a range from 25 to 40 kb (12 strains), with a predominance of plasmids of 30 kb (four strains). Among the four strains carrying two plasmids, all of them carried a 10 kb plasmid and were identified as *Hafnia* sp., *Comamonas* sp., *P. syringae*, and *P. fluorescens* ([Table 6](#T6){ref-type="table"}).

Transfer of Resistance Genes
----------------------------

Among the 22 strains assayed for conjugation experiments, in 10 strains it was demonstrated that *sul* and *dfr* genes, as well as the integrons were transferable. A high frequency of transfer of resistance to sulfonamides was observed in the positive strains, ranging from 10^−3^ to 10^−5^ (transconjugant cells per recipient cells). The majority of these strains (6 out of 10) showed a frequency of transfer of 10^−3^, whereas only two strains showed a frequency of 10^−5^ ([Table 7](#T7){ref-type="table"}). In addition, strains FP75, OP29, OT42, FM7, FM22, and FB98 were able to co-transfer resistance to oxytetracycline, chloramphenicol and florfenicol, whereas strain FR27 co-transferred resistance to chloramphenicol and florfenicol. It was observed that all transconjugant strains acquired similar levels of resistance to antimicrobials to those exhibited by the donor strains.

Six strains used as donors and carrying a class 1 integron were able to transfer this structure as well as their associated gene cassettes ([Table 7](#T7){ref-type="table"}). Furthermore, *sul* and *dfrA* genes not associated with integrons were transferred, corresponding to the *sul1* gene carried by OT42 and FM22 strains, *sul2* gene carried by the FP75 and OP29 strains, and *dfrA12* carried by the SX52 and FR27 strains ([Table 7](#T7){ref-type="table"}). On the contrary, other *dfr* genes not associated with integrons such as the *dfrA12*, *dfrA14*, and *dfrA1* genes carried by the FP45, FB98 and FP75 strains, respectively were not transferred by conjugation ([Table 7](#T7){ref-type="table"}). The simultaneous transfer of *sul1* and *sul2* genes from strains *C. gillenii* FP75 and *K. intermedia* OP29, which carried both genes suggests the location of these genes on the same plasmid, considering that both strains carried only one plasmid. Otherwise, an important number of the assayed strains, both carrying and not carrying a class 1 integron (7 and 5 strains, respectively) were not able to transfer by conjugation their resistance to sulfonamides and/or trimethoprim, as well as the associated resistance encoding genes ([Table 7](#T7){ref-type="table"}).

Discussion
==========

In previous studies investigating resistant strains from Chilean salmon farms with different histories of antimicrobial usage the occurrence of resistance to trimethoprim/sulfametoxazole, accompanied with resistance to florfenicol and oxytetracycline, as well as the carriage of *floR* and *tet* genes respectively has been reported ([@B56]; [@B54]; [@B55]; [@B26]). This was regardless of whether sulfonamides had been used or not, thus suggesting that sulfonamide-resistance may be selected and maintained by the use of other antimicrobials, such as florfenicol or oxytetracycline, the most used antimicrobials in Chilean salmon farms ([@B71]; [@B53]). Furthermore, [@B74] concluded that susceptibility to sulfonamides and trimethoprim will not return after suspending their use, mainly due to the reported high variety of mechanisms of bacterial resistance to these antibacterials, helping to explain the finding of the persistence of these resistances even without selective pressure.

The high incidence of multiresistance exhibited by the studied strains is according with previous studies of antibiotic resistant bacteria recovered from Chilean salmon farms and sites near salmon farms ([@B56]; [@B55]; [@B72]), in which most of strains showed simultaneous resistance to 4--10 antibacterial agents. Otherwise, MIC values of sulfisoxazole and trimethoprim of strains were remarkable high, but no previous MIC values of strains recovered from Chilean salmon farms are available. The high MIC values of these antibacterials suggest the concurrence of *sul* and *dfr* genes.

Among the *sul*-carrying strains, 19 of these strains carried the *sul1* gene associated with the 3′ conserved end, proper of a class 1 integron, as was reported by [@B67], whereas the occurrence of nine strains carrying the *sul1* gene not associated with an integron structure, is in accordance with that reported by [@B31] and [@B37] in clinical strains. On the contrary the detected *sul2* genes were not integron inserted, in agreement with [@B3], who studied *Acinetobacter* strains resistant to sulfametoxazole recovered from fish farms in Thailand. Thus, the positive transfer of *sul2* genes is consistent with a location on another mobile element, such as small size plasmids as was previously reported ([@B66]; [@B24]; [@B8]; [@B3]). As *sul* genes were not detected in 64 sulfonamide-resistant strains, other resistance mechanisms must be involved, most probably multidrug efflux pumps, considering the multiresistant phenotypes of studied strains as well as the high predominance of non-fermenters of glucose, which usually exhibit this mechanism of resistance ([@B50]).

In this study, the *dfrA1, dfrA12*, and *dfrA14* genes were found, with *dfrA12* the most frequent. [@B46] reported these genes encoding for enzymes conferring the highest levels of resistance to trimethoprim, in accordance with this study, because strains carrying *dfr* genes exhibited the highest levels of resistance to trimethoprim. Otherwise, the feasibility of carrying other *dfr* genes cannot be discarded, especially in those strains negative for any of the assayed *dfr* genes and exhibiting high levels of resistance to trimethoprim. It was observed that the majority of assayed strains from F1 and F2 land-based farms (5/6) was not capable of transfer by conjugation their plasmids and *sul* or *dfr* genes, whereas an important number of strains recovered from C1 and C5 lake-based farms (6/8) was able to transfer their integrons as well as their *sul* and *dfr* genes, being included or not in a class 1 integron. Furthermore, considering that transfer of sulfonamide resistance was usually accompanied with a transfer of resistance to the antimicrobials most intensively used in Chilean salmon farms, such as florfenicol and oxytetracycline, these antibacterials might promote the selection and spread of antibiotic resistance genes encoding for sulfonamide and trimethoprim resistance via co-selection.

In a previous study, [@B72] studied a total of 124 strains recovered from aquaculture impacted sediments located near Chilean salmon farms, founding 62 and 58 strains exhibiting resistance to sulfamethizole and trimethoprim, respectively, with 12 strains carrying the *sul1* gene and the integrase-encoding *int1* gene. Otherwise, *dfrA1, dfrA5*, and *dfrA12* genes were detected in 17, 14, and 22 strains, respectively. These authors studied a group of quinolone resistant strains recovered from site near a Chilean salmon farm, and detected three strains identified as *Dietzia* sp., *Rhodococcus* sp., and *Arcobacter* sp., to be carrying class 1 integrons with the *dfrA12*-*aadA2*-*qacEΔ1*-*sul1* array ([@B81]), similar to those shown by the FP75, FB98 and OP29 strains, but lacking the *orfF* gene. Thus, this study reports for the first time the carriage of the gene *dfrA14*, encoding for resistance to trimethoprim as well as the genes *aadA1* and *aadA9*, encoding for resistance to aminoglycosides, among bacteria associated to Chilean salmonid farms, whereas all the observed gene arrays within class 1 integron are described for the first time among bacteria associated to Chilean salmon farming. According to the sequencing analysis, all cassette arrays found in the study have been previously described, mainly associated to enteric bacteria ([@B12]; [@B22]), whereas the gene cassettes identified in the study were not novel.

Most of previous studies dealing with the occurrence of integrons in *Pseudomonas* considered clinical strains belonging to the *Pseudomonas aeruginosa* species. It has been reported that class 1 integrons have been found to be widespread in *P. aeruginosa* isolated from environmental and clinical settings from various countries ([@B27]; [@B33]; [@B13]; [@B69]; [@B49]; [@B41]; [@B42]; [@B35]; [@B2]; [@B40]), in according with the results observed in this study, in which the majority of the strains carrying a class 1 integron belonged to the *Pseudomonas* genus.

After amplifying and DNA sequencing of whole class 1 and integron gene cassettes, a total of six different types of gene cassette arrays were identified, with a predominance of *aadA1* (5 strains) and *aadA2*-*cmlA* (4 strains) ([Table 6](#T6){ref-type="table"}). It is interesting to note the high incidence of *aadA* genes (14 strains), encoding for the enzyme aminoglycoside adenyltransferase that confers resistance to aminoglycosides, inserted in the variable zone of a class 1 integron, considering that no aminoglycosides have been used in Chilean salmon farming, thus suggesting that these integrons have a human clinic origin. In other studies, most of the class 1 integrons identified in *E. coli* strains carried the *dfr12*-*orfF*-*aadA2* cassette array ([@B39]; [@B12]), as was observed in this study for the enteric bacteria.

Otherwise, while the occurrence of *int2* gene in *Pseudomonas aeruginosa* has been previously reported ([@B85]; [@B30]), none of the *Pseudomonas* strains included in this study were found to carry the *int2* gene, which was in concordant to other reports of *P. aeruginosa* from clinical settings ([@B68]; [@B77]; [@B40]). It must be noted that class 2 integrons are not usually detected in *Pseudomonas* strains from environmental sources, being most commonly associated with members of the family Enterobacteriaceae, such as *E. coli* and *Salmonella enterica* ([@B4]; [@B5]; [@B19]; [@B25]; [@B45]; [@B60]).

Of the class 1 integron-containing strains, it was demonstrated the occurrence of an empty integron in seven strains, and possible causes could be the lack of the 3′ conserved segment or insufficient homology to the 3′ conserved segment primer to produce a product such as the observed in strains *Hafnia* sp. FM7, *Pseudomonas putida* FM15, *P. putida* FB15 and *P. putida* FF32, but strains *P. fluorescens* Q20, *P. syringae* Q64 and *P. syringae* FM4 possessed a 3′ conserved segment ([Table 6](#T6){ref-type="table"}). Thus, most probably, the lack of integrated genes cassettes may be a consequence of the excision of previously integrated cassettes from the integron when antibiotic selective pressure is diluted in the environment, as was concluded by [@B69]. Furthermore, these empty structures could confer to these strains the capacity to adapt rapidly to the aquaculture environment, where antibiotics are intensively used, conferring to them a selective advantage by means of the acquisition of new antibiotic resistance genes. Otherwise, it was suggested that these empty structures could be used as indicators of the absence of a sustained antimicrobial pressure ([@B69]).

Otherwise, the absence of the conserved end 3′-CS in four strains carrying class 1 integrons could be a consequence of the activity of insertion sequences which could produce non-functional genes ([@B45]; [@B20]). Furthermore, it must be noted that integrons of environmental bacteria commonly exhibit deletions in their structures, contrary to the observed in the integrons harbored by clinical strains. In this trend, complex integrons associated with the insertion sequence IS*CR1* have been reported ([@B65]; [@B75]), which frequently have non-cassette type resistance genes and a truncated version of 3′-CS region followed by an IS*CR1* element ([@B80],[@B79]). Other studies demonstrated that rearrangements produced by the insertion sequence IS26 in the integrons may change class 1 integron structure causing the loss of parts of the 3′-CS ([@B43]; [@B23]; [@B38]).

The association of integrons inserted in conjugative plasmids and antimicrobial resistance was confirmed by transfer experiments for 10 out of 22 assayed strains. Therefore, integrons appear to have an essential role in facilitating the dissemination of the resistance genes and contributing to the creation of multidrug resistant phenotypes. Furthermore, previous studies demonstrated that copy numbers between the *sul1* and *intI1* genes were significantly correlated suggesting that class 1 integrons may play a role in the prevalence and propagation of *sul1* in various aquatic environments, including farm sediments and marine coastal areas ([@B57]; [@B58]; [@B48]). It is well-known that *intI1* genes are the most abundant gene capture and transmission system in clinical and environmental strains ([@B61]; [@B73]; [@B22]), and their abundance and structures are greatly influenced by anthropogenic contamination ([@B84]). Considering that class 1 integrons are common among multi-drug resistant bacteria inhabiting natural environments associated with human activities, where a strong selection pressure is imposed by the use of antimicrobials, integrons have been proposed as markers for the identification of multi-drug resistant strains, as well as for anthropogenic pollution ([@B28]; [@B29]).

Conclusion
==========

The present results demonstrated that Chilean salmon farms play an important role as reservoirs of sulfonamide- and trimethoprim-resistant bacteria. The prevalence of conjugative plasmids and integrons among *sul*-carrying bacteria suggests these bacteria, mainly belonging to the *Pseudomonas* genus may contribute to high spread of bacterial resistance to sulfonamides and other antibacterials in environments associated with Chilean salmon farms. This is the first study reporting the occurrence of transferable *sul* and *dfr* genes and integrons among the antimicrobial resistant bacteria associated with Chilean salmonid farms and the results suggest that the increasing prevalence of antibiotic resistant bacteria in Chilean salmon farming resistance is partly attributable to the acquisition, dissemination and stable maintenance of a class 1 integron. Thus, a continuous surveillance of these resistance elements even in absence of antibacterial therapy is urgently required to evaluate the potential role of fish farming environments as reservoirs and source of elements composing the mobilome, such as conjugative plasmids and integrons, increasing the risk of their dissemination to human pathogens through horizontal transfer.
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